Clopidogrel-proton pump inhibitor interaction: a primer for clinicians

Area of Science:

• Pharmacology and Therapeutics
• Cardiovascular Medicine
• Gastroenterology

Background:

• Recent alerts from the European Medicines Agency (EMEA) and US Food and Drug Administration (FDA) advised caution regarding clopidogrel and proton pump inhibitor (PPI) use.
• These agencies recommended amending product information to discourage concomitant use of PPIs with clopidogrel unless essential, citing potential interference with clopidogrel's effectiveness.
• Concerns have been raised by experts regarding the overemphasis of this interaction, as supporting evidence primarily stems from observational studies.

Purpose of the Study:

• To critically analyze the available data on the interaction between clopidogrel and proton pump inhibitors (PPIs).
• To provide practical guidance for clinicians on the appropriate use of PPIs in patients undergoing clopidogrel therapy.
• To inform clinical decision-making by balancing gastrointestinal and thrombotic risks.

Main Methods:

• Critical review and analysis of existing clinical studies and observational data concerning the clopidogrel-PPI interaction.
• Evaluation of the evidence base supporting the purported interaction.
• Synthesis of findings to develop evidence-based recommendations for clinical practice.

Main Results:

• The evidence suggesting a significant clopidogrel-PPI interaction is largely derived from observational studies, prompting debate about its clinical importance.
• A comprehensive assessment of available data is necessary to understand the true impact of PPIs on clopidogrel efficacy.
• Individual patient factors, including gastrointestinal risk and thrombotic risk, are crucial in the decision-making process.

Conclusions:

• The decision to co-prescribe PPIs to patients on clopidogrel should be individualized, weighing the benefits of gastroprotection against potential antiplatelet therapy compromise.
• Proton pump inhibitors should be reserved for patients with a clear, appropriate indication when taking clopidogrel.
• Further research may be warranted to definitively elucidate the clinical significance of this drug interaction.